Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Redemption of Ordinary Shares and Shareholder Engagement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Diagonal Bio AB’s warrant exercise registered at the Swedish Companies Registration Office

Diagonal Bio AB ("Diagonal" or the "Company") today announces that the new shares from the exercise of warrants of series TO 1 have been registered with the Swedish Companies Registration Office.On 26 September 2024, the exercise period for warrants of series TO 1, which were issued in connection with Diagonal’s rights issue of units earlier in 2024, ended. As a result of the warrant exercise, 77.794 new shares have now been registered with the Swedish Companies Registration Office. The total number of shares in the Company after the exercise of warrants of series TO 1 amount to 400.714.213

Read original

#24-344 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-343 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Post Stabilisation Notice

Post Stabilisation Notice   October 02, 2024   Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.   mBank S.A. EUR 500,000,000 4.034% Green Bonds senior preferred Notes due 2030 Launched pursuant to the Issuer’s EMTN Programme   Commerzbank (contact: Ian Turner; telephone: +44 207 475 1817) hereby gives notice that no stabilisation (within the meaning of Article 3.2 (d) of the Market Abuse Regulation (EU Regulation 596/2014) was undertaken by the Stabilising Managers named

CS MEDICA A/S Secures Sales Approval in Azerbaijan & Georgia, Valued at 1.17 mDKK

Successfully converting pipeline orders into sales through regulatory approval, while expanding the pipeline in the South Africa Region, valued at 2.5 mDKK post-registration.CS MEDICA A/S, a Danish MedTech company specializing in pain management and autoimmune treatments, announces the successful completion of the registration process for its CANNASEN® medical device products in Azerbaijan and Georgia. The company is now ready for sales in these regions. Since March 2024, CS MEDICA has been engaged in the registration process for its Pain & Arthritis Gel, Psoriasis Gel, and Nasal Night

SVM UK Emerging Fund Plc Quarterly Disclosure

SVM UK Emerging Fund PlcQuarterly Disclosure – 02 October 2024  In accordance with UKLA Listing Rule 15.6.8, requiring UK listed investmentcompanies to notify, within five business days of the end of each quarter, alist of all investments in other investment companies that do not have astated investment policy to invest no more than 15% of their gross assets inother UK-listed investment companies (including investment trusts), SVM UKEmerging Fund Plc announces that, as at 30 September 2024, it had noinvestments in such other investment companies.    For further

CS MEDICA A/S Share Capital Increase Registered with the Danish Companies Registration Office

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces that the resolutions passed at its Extraordinary General Meeting (EGM) held on July 31, 2024, together with the issuance of bonus warrants following §3.1.4.2 of the Articles of Association, have now been registered with the Danish Companies Registration Office. As a result, the Company’s share capital has increased from DKK 854,022.28 to DKK 897,342.84, with the total number of registered shares increasing by 1,482,670 shares, accumulating to a total of 13,805,305 shares in CS MEDICA.

Report from the Extraordinary General Meeting in Wyld Networks AB

The Extraordinary General Meeting in Wyld Networks AB ("Wyld Networks" or the "Company") was held today, 2 October 2024, whereby the shareholders passed the following resolutions. Approval of the board of directors' resolution regarding issuance of units with preferential rights for the shareholders and amendments to the articles of association The Extraordinary General Meeting resolved to approve the board of directors' resolution from 2 September 2024 to carry out a new issue of shares and warrants, so called units, with preferential rights for the Company's shareholders. The record

Edison Investment Research increases valuation of Cereno Scientific to 3.9 BSEK or SEK 13.9 SEK/share after positive topline data

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that Edison Investment Research increases their valuation of the Company to SEK 3.9 BSEK or 13.9 SEK/share.Read the full research note here . The increased valuation comes at the heels of Cereno reporting positive topline results  from the Phase IIa trial of lead drug

GomSpace signs 3.6 MSEK standard platform contract with UK university partnership

The universities of Surrey, Portsmouth and Southampton, UK, three of the European leading Space Universities have selected GomSpace to supply a 3.6 MSEK platform kit for an upcoming express mission.The three universities, which are partners in the Space South Central  region of Surrey and Hampshire in the UK, are collaborating on JUPITER – the Joint Universities Programme for In-orbit Training, Education and Research. Their first mission is Jovian-1, a satellite with five payloads, one of which will be entirely developed by students, building vital space

SSAB celebrates Global Diversity Awareness Month in October

SSAB is excited to celebrate Global Diversity Awareness Month, a time to recognize and appreciate the diverse cultures, perspectives, and experiences within our workplace. This celebration is about embracing our differences as strengths that drive innovation and growth. We are all different   A diverse workplace brings together individuals from various backgrounds, each contributing unique viewpoints and ideas. It also fosters a dynamic and inclusive environment where everyone feels valued and heard. Celebrating Global Diversity Awareness Month reaffirms SSAB’s commitment to

Shape Robotics live Q&A – Business updates

Shape Robotics A/S, a leader in educational robotics, recently organized a live Q&A session for the investors community in order to offer updates regarding relevant business operations and other developments. This event is part of an ongoing series of events to be organized for the investors’ community. During the live session, Mark Abraham, CEO, together with Marius Vasile, Vice-President for channel sales, responded to several questions received from shareholders and also communicated information regarding the current status of the business. In summary, the following topics were

Borr Drilling Limited - Summons for a written resolution – Senior Unsecured Convertible Bond Loan 2023/2028

Borr Drilling Limited (the "Company") has today requested Nordic Trustee AS to summon for a bondholders' written resolution (the "Summons") for the Company's senior unsecured convertible bonds with ISIN NO0012828187 (the "Bonds"). The purpose of the written resolution is to approve a proposal to amend the bond terms in connection with the potential de-listing of the Company’s shares from the Oslo Stock Exchange, as approved by a Special General Meeting of the shareholders of the Company on October 1, 2024. The company has received support from more than 2/3 of the Bondholders having

EQT Broadens Reworld™ Investor Base, Welcoming GIC as Strategic Investor

· GIC to acquire a 25% minority interest in Reworld Waste, LLC · Broadened investor base adds new resources, expertise, and capital that will help accelerate the Company’s journey as one of North America’s leading sustainable waste solutions companiesEQT and GIC are pleased to announce that the EQT Infrastructure V fund (“EQT Infrastructure”) has signed an agreement to sell a 25% minority stake in Reworld™ (“the Company”) to GIC via a combination of primary and secondary capital. EQT Infrastructure took the Company private in November 2021 and will remain the largest shareholder

Invitation to the presentation of Gjensidige's results for the 3rd quarter 2024

Gjensidige Forsikring (OSE:GJF) will publish the results for the 3rd quarter 2024 on 22 October at 7.00 CET. 22 October (Oslo) 9.00 CET CEO Geir Holmgren and CFO Jostein Amdal will present the results in a combined webcast and conference call. The presentation and following Q&A session will be held in English. The webcast can be viewed live on www.gjensidige.com/ir. Participants who would like to ask questions can dial in using one of the telephone numbers below. The full presentation can also be listened to live, using the same dial-in details. Dial-in details:Norway: +47

Basis swap and AT1 impact Q3 2024

In the third quarter of 2024, the DNB Group will recognise a negative mark-to-market effect of NOK 194 million from basis swaps connected to funding. Furthermore, a negative effect of NOK 19 million from the USD and SEK Additional Tier 1 capital will also be recognised. The effects will appear under Net gains on financial instruments at fair value in our financial statement. For further information, please contact:Rune Helland, Head of Investor Relations, tel.: (+47) 23 26 84 00 / (+47) 97 71 32 50

Metso invests in energy-saving future comminution technology by acquiring its long-term partner Swiss Tower Mills Minerals

Metso Corporation’s press release on October 2, 2024, at 2:00 p.m. EESTMetso is investing in the development of energy-saving comminution technology and has signed an agreement to acquire the outstanding shares of its long-term partner Swiss Tower Mills Minerals AG (STM). Previously, Metso had a 15% minority ownership in the company. The parties have agreed not to disclose the transaction value. Metso decided to exercise its right of first refusal following the divestment decision of STM’s other shareholders. As a result of the transaction, Metso’s ownership will increase to 100%. Metso

AGRIA LAUNCHES ITS GAME-CHANGING HORSE INSURANCE IN IRELAND

Cork, Ireland – 2nd October, 2024 – Agria, a leading European provider of pet insurance, is proud to announce the launch of Ireland's first-ever comprehensive horse insurance policy covering veterinary fees. This policy is designed to provide horse owners with peace of mind, offering protection against unexpected medical costs.Lifetime equine insurance, which covers horses for vet fees, loss of use and mortality, is now launching in Ireland, and sets the standard in vet fee cover because:  · Chronic conditions or ongoing injuries — providing they first arise once the cover is in place —

There are no items matching the current filter
There are no more items matching the current filter
Back to top